Arcellx, Inc. (ACLX)
114.34
+0.04
(+0.04%)
USD |
NASDAQ |
Mar 05, 16:00
114.34
0.00 (0.00%)
After-Hours: 18:45
Arcellx Cash from Investing (TTM) : 86.30M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Gilead Sciences, Inc. | -4.793B |
| Eli Lilly & Co. | -10.97B |
| Johnson & Johnson | -23.59B |
| Merck & Co., Inc. | -13.74B |
| Amicus Therapeutics, Inc. | -46.43M |